{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:44:02Z","timestamp":1792212242497,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.eururo.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T14:03:49Z","timestamp":1342620229000},"page":"158-165","source":"Crossref","is-referenced-by-count":73,"title":["Solifenacin Plus Tamsulosin Combination Treatment in Men With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction: A Randomized Controlled Trial"],"prefix":"10.1016","volume":"63","author":[{"given":"Steven A.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Koltun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allam","family":"Fakhoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2012.07.003_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1464-410X.2009.08369.x","article-title":"The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS","volume":"103","author":"Sexton","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.07.003_bib0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","article-title":"The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study","volume":"101","author":"Coyne","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.07.003_bib0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ncpuro0754","article-title":"Defining the role of overactive bladder treatments in men with lower urinary tract symptoms","volume":"4","author":"Lemack","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.07.003_bib0040","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2012.07.003_bib0045","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.juro.2009.08.023","article-title":"Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency","volume":"182","author":"Kaplan","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.1999.00121.x","article-title":"Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function","volume":"84","author":"Abrams","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.07.003_bib0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1742-1241.2010.02611.x","article-title":"Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review","volume":"65","author":"Kaplan","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2012.07.003_bib0060","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2008.11.026","article-title":"Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with \u03b1-blockers","volume":"56","author":"Chapple","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urology.2011.02.055","article-title":"Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms\u2014ASSIST, randomized controlled study","volume":"78","author":"Yamaguchi","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.07.003_bib0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1757-5672.2010.00081.x","article-title":"Randomized controlled trial to treat benign prostatic hyperplasia with overactive bladder using an alpha-blocker combined with anticholinergics","volume":"3","author":"Nishizawa","year":"2011","journal-title":"LUTS: Lower Urinary Tract Symptoms"},{"key":"10.1016\/j.eururo.2012.07.003_bib0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eururo.2011.03.054","article-title":"The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update","volume":"60","author":"Athanasopoulos","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0080","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0085","unstructured":"A study with combination treatment [tamsulosin hydrochloride and solifenacin succinate] in male patients with LUTS\/BPH (SATURN) [identifier NCT00510406]. ClinicalTrials.gov Web site. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00510406."},{"key":"10.1016\/j.eururo.2012.07.003_bib0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MOU.0b013e3283330862","article-title":"Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia","volume":"20","author":"Chapple","year":"2010","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0095","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/01.ju.0000173630.94559.fd","volume":"174","author":"Lee","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.07.003_bib0100","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1464-410X.2011.10624.x","article-title":"Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving \u03b1-blocker treatment for lower urinary tract symptoms","volume":"109","author":"Kaplan","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.07.003_bib0105","unstructured":"Van Kerrebroeck P, Oelke M, Katona F, Garcia-Hernandez A, Klaver M. Efficacy of tamsulosin OCAS plus solifenacin (TOCAS plus soli) in male LUTS: results from a randomised, dose-ranging, Phase II trial (SATURN). Poster presented at: Soci\u00e9t\u00e9 Internationale d\u2019Urologie World Meeting on Lower Urinary Tract Dysfunction; October 13\u201316, 2010; Marrakech, Morocco."},{"key":"10.1016\/j.eururo.2012.07.003_bib0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000020356","article-title":"Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention: Combined experience from three large multinational placebo-controlled trials","volume":"38","author":"Marberger","year":"2000","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812008081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812008081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T21:09:05Z","timestamp":1642799345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812008081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0302283812008081"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.07.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717953906.793470759","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717953906.793466023","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717953906.793459601","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}